| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |